| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $593.8M | $573.4M | $551.5M |
| YoY Revenue Growth % | +3.6% | +4.0% | — |
| Gross Profit | $270.3M | $254.6M | — |
| Gross Margin % | 45.5% | 44.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$26.8M | -$51.3M | -$61.2M |
| Operating Margin % | -4.5% | -8.9% | -11.1% |
| Net Income (GAAP) | -$55.8M | -$164.9M | -$14.6M |
| EBITDA (Normalized) | $241.6K | -$21.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $72.2M | $49.7M | $5.8M |
| Capital Expenditures (CapEx) | $33.9M | $37.4M | — |
| Free Cash Flow (FCF) | $38.3M | $12.4M | $5.8M |
| FCF Margin % | 6.5% | 2.2% | 1.1% |
| Return on Invested Capital (ROIC %) | -1.5% | -3.0% | — |
| Cash & Short-Term Equivalents | $336.6M | $377.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.71B | $1.72B | — |